Dr. Paul Bryant Glisson, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 750 Morphy Ave, Fairhope, AL 36532 Phone: 251-990-1150 |
Dr. Vernon Lyle Hermecz, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 750 Morphy Ave, Fairhope, AL 36532 Phone: 251-990-1150 |
Jonathan Mark Hardin, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 Morphy Ave, Fairhope, AL 36532 Phone: 251-928-2375 |
Donald Martin Williams, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 750 Morphy Ave, Fairhope, AL 36532 Phone: 251-990-1150 |
Russell Staggs, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 750 Morphy Ave, Fairhope, AL 36532 Phone: 251-928-2375 |
Kaleigh Elizabeth Miller, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 750 Morphy Ave, Fairhope, AL 36532 Phone: 251-990-1151 |
Avery Lee Thornhill Callahan, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 Morphy Ave, Fairhope, AL 36532 Phone: 519-282-3752 |
Dr. Rolland S Olds, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 750 Morphy Ave, Fairhope, AL 36532 Phone: 251-990-1150 |
Casey Andrew Mcintosh, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 Morphy Ave, Fairhope, AL 36532 Phone: 251-279-1151 |
Matthew James Callahan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 750 Morphy Ave, Fairhope, AL 36532 Phone: 251-928-2375 |
Dr. Kelly L Garcia, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 750 Morphy Ave, Fairhope, AL 36532 Phone: 251-402-3488 |
News Archive
A team of investigators led by researchers at Georgetown Lombardi Comprehensive Cancer Center has found that the tumor mutation load, or TML, in a patient's cancer biopsy varied by age and the type of cancer, along with several other factors.
The U.S. Food and Drug Administration today approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia who have a specific genetic mutation called FLT3, in combination with chemotherapy.
Par Pharmaceutical Companies, Inc. today announced that its Par Pharmaceutical, Inc. operating subsidiary has entered into an exclusive acquisition and license agreement with Handa Pharmaceuticals, LLC to acquire Handa's Abbreviated New Drug Application (ANDA) for quetiapine fumarate extended-release tablets, the generic version of AstraZeneca's Seroquel XR.
Investments in agricultural technology should be directed to Africa's smallholder farmers in an effort to increase food security after decades of low funding, the U.N. Conference on Trade and Development (UNCTAD) said in a report on Wednesday, Reuters reports (Lynn, 5/19).
› Verified 1 days ago